Safety of budesonide inhalation suspension in infants aged six to twelve months with mild to moderate persistent asthma or recurrent wheeze
- 31 January 2005
- journal article
- clinical trial
- Published by Elsevier in The Journal of Pediatrics
- Vol. 146 (1) , 91-95
- https://doi.org/10.1016/j.jpeds.2004.08.060
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Safety profile of budesonide inhalation suspension in the pediatric population: worldwide experienceAnnals of Allergy, Asthma & Immunology, 2004
- Nebulized Budesonide Inhalation Suspension Compared With Cromolyn Sodium Nebulizer Solution for Asthma in Young Children: Results of a Randomized Outcomes TrialPediatrics, 2002
- Effects of budesonide inhalation suspension on hypothalamic-pituitary-adrenal-axis function in infants and young children with persistent asthmaAnnals of Allergy, Asthma & Immunology, 2002
- Effect of Long-Term Treatment with Inhaled Budesonide on Adult Height in Children with AsthmaNew England Journal of Medicine, 2000
- Long-Term Effects of Budesonide or Nedocromil in Children with AsthmaNew England Journal of Medicine, 2000
- Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young childrenAnnals of Allergy, Asthma & Immunology, 1999
- A Multiple-dosing, Placebo-controlled Study of Budesonide Inhalation Suspension Given Once or Twice Daily for Treatment of Persistent Asthma in Young Children and InfantsPublished by American Academy of Pediatrics (AAP) ,1999
- Efficacy and safety of budesonide inhalation suspension (Pulmicort Respules) in young children with inhaled steroid–dependent, persistent asthmaJournal of Allergy and Clinical Immunology, 1998
- Hypothalamic-Pituitary-Adrenal Axis Suppression and Inhaled Corticosteroid TherapyNeuroimmunomodulation, 1998
- Clinical review 62: Laboratory assessment of adrenal insufficiencyJournal of Clinical Endocrinology & Metabolism, 1994